WASHINGTON, Jan. 11 (UPI) -- The anticipated approval of a new dosing regimen for AstraZeneca's Symbicort in Europe could significantly alter the asthma drug market, analysts said Wednesday. The ...
Asthma diagram, lungs Breyna is a metered-dose inhaler containing budesonide, a corticosteroid, and formoterol, a long-acting bronchodilator. The Food and Drug Administration (FDA) has approved ...
AstraZeneca Announces Symbicort Is Now Available In The U.S. U.S. Asthma Sufferers Now Have a New Choice of Combination Therapy to Help Achieve Asthma Control LONDON ...
(RTTNews) - The U.S. Food and Drug Administration approved Mylan Pharmaceuticals, Inc.'s generic of Symbicort (budesonide and formoterol fumarate dihydrate) inhalation aerosol. It is the first FDA- ...
Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of asthma, surveyed physicians’ prescribing practices ...
London, UK, Thursday 23 March 2023 – AstraZeneca today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing ...
Viatris’ new drug-device is the first FDA-approved generic version of AstraZeneca’s Symbicort. Kindeva Drug Delivery, a contract development and manufacturing organization, and Viatris announced FDA ...
The studies examined the efficacy of Symbicort pressurized metered dose inhaler (pMDI) 160/4.5mcg vs. formoterol 4.5mcg in reducing COPD exacerbations in adults with moderate to severe COPD. The FDA ...
The results showed a a 51% reduction in the rate of annual asthma exacerbations compared to albuterol. AstraZeneca’s Novel START trial for its Symbicort Turbuhaler ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback